Deccan Health Care Peer Comparison

BSE: 542248

₹12.69

₹0.19 (1.52%)

As on 04-Sep-2026IST

Market cap

₹31 Cr

Revenue (TTM)

₹82 Cr

P/E Ratio

12.4

P/B Ratio

0.3

Div. Yield

0 %

Edit

	Deccan Health Care	Caplin Point Lab	Pfizer	Shilpa Medicare	Eris Lifesciences
Market cap (₹ Cr)	31	21,361	21,107	18,873	18,390
Revenue (₹ Cr)	82	2,287	2,570	1,682	3,230
Net Profit (₹ Cr)	2.54	678.07	735.15	273.51	666.92
Net Margin (%)	3.11	28.10	26.88	16.19	20.60
RoE (%)	2.32	19.73	19.16	11.15	18.75
Price to Earnings	12.36	32.11	28.71	63.48	28.56
Price-To-Book	0.28	5.67	4.79	7.03	4.56

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Deccan Health Care	Caplin Point Lab	Pfizer	Shilpa Medicare	Eris Lifesciences
Operating Revenue	81.83	2,287.33	2,569.77	1,682.47	3,229.67
Total Income	81.86	2,413.29	2,735.39	1,689.83	3,237.12
Total Expenditure	76.59	1,490.75	1,628.14	1,203.91	2,090.06
EBITDA	5.24	796.58	941.63	478.55	1,139.61
Depreciation	1.44	78.10	57.58	126.01	281.06
EBIT	3.80	718.48	884.05	352.55	858.55
Interest	0.51	0.88	7.69	52.11	190.64
Other Income	0.03	125.96	165.62	7.37	7.45
Exceptional Items	0.00	0.00	-49.16	12.16	-17.24
Profit before Tax	3.32	843.56	992.82	319.96	658.12
Provision for Tax	0.78	165.49	257.67	46.45	-8.80
Profit after Tax	2.54	678.07	735.15	273.51	666.92

Liabilities (₹ Cr)

	Deccan Health Care	Caplin Point Lab	Pfizer	Shilpa Medicare	Eris Lifesciences
Shareholder's Funds	110.26	3,586.42	4,202.90	2,591.20	3,902.67
Minority Interest	0.00	-12.71	0.00	0.00	-21.81
Non-Current Liabilities	4.60	28.74	91.50	266.35	1,392.75
Current Liabilities	34.05	385.94	627.48	848.06	2,077.10
Total Liabilities	124.93	3,207.85	4,911.11	3,310.68	6,865.52

Assets (₹ Cr)

	Deccan Health Care	Caplin Point Lab	Pfizer	Shilpa Medicare	Eris Lifesciences
Non-Current Assets	15.02	1,291.22	770.28	2,525.44	5,617.77
Current Assets	129.73	2,585.66	3,803.22	1,109.77	1,539.85
Total Assets	124.93	3,207.85	4,911.11	3,310.68	6,865.52
Total Debt*	1.15	0.55	2.50	586.37	2,421.66
Net Current Assets	95.68	2,199.72	3,175.74	261.71	-537.25
Contingent Liabilities	16.77	0.64	363.79	76.22	51.96

Cashflow (₹ Cr)

	Deccan Health Care	Caplin Point Lab	Pfizer	Shilpa Medicare	Eris Lifesciences
Cash From Operating Activities	-6.43	432.37	659.75	132.27	1,065.01
Cash Flow from Investing Activities	-0.14	-334.73	-71.34	-199.13	-79.97
Cash from Financing Activities	7.52	-38.32	-205.34	62.65	-881.32
Net Cash Inflow / Outflow	0.95	59.32	383.07	-4.21	103.72

Ratios

Profitability Ratios

	Deccan Health Care	Caplin Point Lab	Pfizer	Shilpa Medicare	Eris Lifesciences
ROCE (%)	1.65	26.22	26.21	6.95	13.59
ROE (%)	2.32	19.73	19.16	11.15	18.75
ROA (%)	1.86	18.69	14.95	7.80	9.26
EBIT Margin (%)	4.64	31.41	34.40	20.95	26.58
Net Margin (%)	3.11	28.10	26.88	16.19	20.60
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Deccan Health Care	Caplin Point Lab	Pfizer	Shilpa Medicare	Eris Lifesciences
Revenue Growth (%)	-0.37	15.01	10.69	27.91	9.59
EBIT Growth (%)	147.01	18.45	24.14	58.32	16.84
Net Profit Growth (%)	146.51	19.61	-9.09	149.56	62.68
EPS Growth (%)	124.86	17.73	14.40	-3.57	67.41
Book Value Growth (%)	10.15	23.77	17.30	30.63	10.19

Valuation Ratios

	Deccan Health Care	Caplin Point Lab	Pfizer	Shilpa Medicare	Eris Lifesciences
Price / Earnings	12.18	32.11	27.36	67.34	27.87
Price / Book Value	0.28	5.67	4.79	7.03	4.56
Dividend Yield (%)	0.00	0.28	1.63	0.06	0.00
EV/EBITDA	5.53	25.55	19.11	40.72	18.10
Market Cap (₹ Cr)	39.68	15,219.80	18,318.10	6,484.12	19,292.77

Solvency Ratios

	Deccan Health Care	Caplin Point Lab	Pfizer	Shilpa Medicare	Eris Lifesciences
Debt to Equity	0.02	0.00	0.00	0.07	0.24
Short term debt to equity ratio	--	0.00	0.00	0.13	0.14
Current Ratio	3.81	6.70	6.06	1.31	0.74
Quick Ratio	2.43	5.59	5.31	0.88	0.53
Interest Coverage	7.58	959.59	130.11	7.14	4.45

Operating Efficiency Ratios

	Deccan Health Care	Caplin Point Lab	Pfizer	Shilpa Medicare	Eris Lifesciences
Debtors to sales (%)	20.76	36.10	7.07	30.84	21.07
Asset Turnover	0.60	0.63	0.52	0.48	0.45
Receivable days	54.52	110.70	29.10	118.15	54.06
Inventory Days	214.70	65.86	69.53	98.29	32.16
Payable days	50.95	105.88	76.77	128.16	140.91
Cash Conversion Cycle	218.27	70.68	21.86	88.28	-54.69

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.